Parham Richelle P, a director at Labcorp Holdings Inc., has filed a notice to sell 1,078 shares of the company's common stock. This transaction, filed on October 30, 2026, highlights potential adjustments in insider ownership at the medical laboratory services firm.

Labcorp Holdings Inc., known for its comprehensive laboratory services, operates under the Standard Industrial Classification of Medical Laboratories. The company, with a central index key of 0000920148, has undergone name changes in the past, previously known as Laboratory Corp of America Holdings. The filing indicates that the shares are being sold through Fidelity Brokerage Services LLC, a well-known brokerage firm.

According to the filing, the aggregate market value of the shares being sold is approximately $389,395.16. Richelle Parham acquired these shares through restricted stock vesting as part of her compensation on February 9, 2017. The filing does not indicate any sales of securities by Parham in the past three months.

This insider sale may impact Labcorp's stakeholders, including investors and employees, as it reflects the director's decision to adjust her holdings. The medical laboratories sector, in general, may also experience scrutiny as insider transactions can signal confidence or concerns about a company's future.

Details were not available in the SEC filing regarding any subsequent actions or future filings related to this transaction.